[
  {
    "ts": null,
    "headline": "Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026",
    "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.",
    "url": "https://finnhub.io/api/news?id=b3c3c44580c19c02787cac9573367f29a8f9a06d9e707fa1e75488b8445fdd6b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767884400,
      "headline": "Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026",
      "id": 138037237,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.",
      "url": "https://finnhub.io/api/news?id=b3c3c44580c19c02787cac9573367f29a8f9a06d9e707fa1e75488b8445fdd6b"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?",
    "summary": "BSX is seeing solid international growth, MedSurg market-share gains and surging WATCHMAN sales, though macro and competition remain risks.",
    "url": "https://finnhub.io/api/news?id=2d12c005391349579ff478a4fe46ec854dd30687d56e86bb0a1d0ee8a4fe2e90",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767878820,
      "headline": "Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?",
      "id": 138036814,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "BSX is seeing solid international growth, MedSurg market-share gains and surging WATCHMAN sales, though macro and competition remain risks.",
      "url": "https://finnhub.io/api/news?id=2d12c005391349579ff478a4fe46ec854dd30687d56e86bb0a1d0ee8a4fe2e90"
    }
  },
  {
    "ts": null,
    "headline": "Is This the Right Time to Add Resmed Stock to Your Portfolio?",
    "summary": "RMD is seeing rising device demand, expanding international sales and strong liquidity, but macroeconomic pressures could weigh on future performance.",
    "url": "https://finnhub.io/api/news?id=79294274c4ae347b3fa4669f76d1521e12393161b3564a3d3264eb228116b05c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767877020,
      "headline": "Is This the Right Time to Add Resmed Stock to Your Portfolio?",
      "id": 138037166,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "RMD is seeing rising device demand, expanding international sales and strong liquidity, but macroeconomic pressures could weigh on future performance.",
      "url": "https://finnhub.io/api/news?id=79294274c4ae347b3fa4669f76d1521e12393161b3564a3d3264eb228116b05c"
    }
  },
  {
    "ts": null,
    "headline": "Is It Time To Reassess Quest Diagnostics (DGX) After Recent Share Price Strength?",
    "summary": "If you are wondering whether Quest Diagnostics shares still offer good value at around US$178.14, the key question is how that price compares with what the business might reasonably be worth. The stock has returned 2.7% over the last week and 2.5% year to date, with a 17.8% return over the past year and 56.6% over five years. These figures may affect how you think about potential upside or downside from here. Recent attention on Quest Diagnostics has centered on its role as a major medical...",
    "url": "https://finnhub.io/api/news?id=a88827e46c5ff51d0a75c30605fd394e88df33b336abec3438dfdc6a30b29377",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767834948,
      "headline": "Is It Time To Reassess Quest Diagnostics (DGX) After Recent Share Price Strength?",
      "id": 138033864,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "If you are wondering whether Quest Diagnostics shares still offer good value at around US$178.14, the key question is how that price compares with what the business might reasonably be worth. The stock has returned 2.7% over the last week and 2.5% year to date, with a 17.8% return over the past year and 56.6% over five years. These figures may affect how you think about potential upside or downside from here. Recent attention on Quest Diagnostics has centered on its role as a major medical...",
      "url": "https://finnhub.io/api/news?id=a88827e46c5ff51d0a75c30605fd394e88df33b336abec3438dfdc6a30b29377"
    }
  }
]